Product information
From Health Canada
Current status:
Marketed
Current status date:
2005-12-23
Original market date: See footnote 1
2001-02-27
Product name:
SANDOZ ORPHENADRINE
DIN:
02243559 Electronic product monograph is not available
Company:
SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada
J4B 1E6
Class:
Human
Dosage form(s):
Tablet (Extended-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
12:20.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
M03BC01 ORPHENADRINE (CITRATE)
Active ingredient group (AIG) number:See footnote5
0102078001
Active ingredient(s) | Strength |
---|---|
ORPHENADRINE CITRATE | 100 MG |